Annual Shareholders Equity
$77.69 M
-$48.96 M-38.66%
31 December 2023
Summary:
Summit Therapeutics annual stockholders equity is currently $77.69 million, with the most recent change of -$48.96 million (-38.66%) on 31 December 2023. During the last 3 years, it has fallen by -$1.76 million (-2.22%). SMMT annual shareholders equity is now -38.66% below its all-time high of $126.65 million, reached on 31 December 2022.SMMT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$437.92 M
+$242.84 M+124.49%
30 September 2024
Summary:
Summit Therapeutics quarterly stockholders equity is currently $437.92 million, with the most recent change of +$242.84 million (+124.49%) on 30 September 2024. Over the past year, it has increased by +$338.54 million (+340.66%). SMMT quarterly shareholders equity is now at all-time high.SMMT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SMMT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.7% | +340.7% |
| 3 y3 years | -2.2% | +328.1% |
| 5 y5 years | +39.3% | +1163.7% |
SMMT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.7% | at low | at high | +890.5% |
| 5 y | 5 years | -38.7% | +39.3% | at high | +1163.7% |
| alltime | all time | -38.7% | +1841.3% | at high | +4344.6% |
Summit Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $437.92 M(+124.5%) |
| June 2024 | - | $195.07 M(+341.2%) |
| Mar 2024 | - | $44.21 M(-43.1%) |
| Dec 2023 | $77.69 M(-38.7%) | $77.69 M(-21.8%) |
| Sept 2023 | - | $99.38 M(-16.9%) |
| June 2023 | - | $119.60 M(-10.4%) |
| Mar 2023 | - | $133.48 M(+5.4%) |
| Dec 2022 | $126.65 M(+52.1%) | $126.65 M(-4.9%) |
| Sept 2022 | - | $133.25 M(+159.7%) |
| June 2022 | - | $51.32 M(-20.3%) |
| Mar 2022 | - | $64.41 M(-22.7%) |
| Dec 2021 | $83.28 M(+4.8%) | $83.28 M(-18.6%) |
| Sept 2021 | - | $102.30 M(-14.3%) |
| June 2021 | - | $119.43 M(+85.4%) |
| Mar 2021 | - | $64.41 M(-18.9%) |
| Dec 2020 | $79.45 M(+0.7%) | - |
| Dec 2020 | - | $79.45 M(+115.5%) |
| Sept 2020 | - | $36.86 M(-45.4%) |
| Mar 2020 | - | $67.46 M(+94.7%) |
| Dec 2019 | $78.86 M(+41.4%) | - |
| Oct 2019 | - | $34.65 M(-15.5%) |
| July 2019 | - | $40.99 M(-18.0%) |
| Apr 2019 | - | $49.97 M(-10.4%) |
| Jan 2019 | $55.79 M(-1350.4%) | - |
| Jan 2019 | - | $55.79 M(+56.6%) |
| Oct 2018 | - | $35.63 M(-17.9%) |
| July 2018 | - | $43.41 M(+446.1%) |
| Apr 2018 | - | $7.95 M(-278.2%) |
| Jan 2018 | -$4.46 M(+2.2%) | - |
| Jan 2018 | - | -$4.46 M(-121.0%) |
| Oct 2017 | - | $21.28 M(+362.5%) |
| July 2017 | - | $4.60 M(-144.6%) |
| Apr 2017 | - | -$10.32 M(+136.3%) |
| Jan 2017 | -$4.37 M(-119.1%) | - |
| Jan 2017 | - | -$4.37 M(-428.3%) |
| Oct 2016 | - | $1.33 M(-90.5%) |
| July 2016 | - | $13.97 M(-41.5%) |
| Apr 2016 | - | $23.86 M |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2016 | $22.90 M(+17.3%) | - |
| Jan 2016 | - | $22.90 M(-42.7%) |
| Oct 2015 | - | $39.98 M(-15.2%) |
| July 2015 | - | $47.14 M(-9.8%) |
| Apr 2015 | - | $52.25 M(+167.5%) |
| Jan 2015 | $19.53 M(+148.6%) | - |
| Jan 2015 | - | $19.53 M(-30.9%) |
| Oct 2014 | - | $28.25 M(-16.5%) |
| July 2014 | - | $33.82 M(+330.5%) |
| Jan 2014 | $7.86 M(+74.4%) | - |
| Jan 2014 | - | $7.86 M(-1.9%) |
| July 2013 | - | $8.01 M(+77.8%) |
| Jan 2013 | $4.50 M(+19.2%) | - |
| Jan 2013 | - | $4.50 M(-40.0%) |
| July 2012 | - | $7.51 M(+98.7%) |
| Jan 2012 | $3.78 M(-35.1%) | - |
| Jan 2012 | - | $3.78 M(-34.5%) |
| July 2011 | - | $5.77 M(-0.9%) |
| Jan 2011 | $5.82 M(-56.0%) | - |
| Jan 2011 | - | $5.82 M(-43.3%) |
| July 2010 | - | $10.27 M(-22.3%) |
| Jan 2010 | $13.22 M(+7.3%) | - |
| Jan 2010 | - | $13.22 M(+40.6%) |
| July 2009 | - | $9.41 M(-23.7%) |
| Jan 2009 | $12.33 M(-77.2%) | - |
| Jan 2009 | - | $12.33 M(-73.9%) |
| July 2008 | - | $47.29 M(-12.6%) |
| Jan 2008 | $54.08 M(+34.8%) | - |
| Jan 2008 | - | $54.08 M(-17.8%) |
| July 2007 | - | $65.79 M(+64.0%) |
| Jan 2007 | $40.11 M(+71.6%) | - |
| Jan 2007 | - | $40.11 M(-2.7%) |
| July 2006 | - | $41.21 M(+76.3%) |
| Jan 2006 | $23.38 M(-11.9%) | - |
| Jan 2006 | - | $23.38 M(-4.6%) |
| July 2005 | - | $24.51 M(-7.6%) |
| Jan 2005 | $26.53 M | - |
| Jan 2005 | - | $26.53 M(<-9900.0%) |
| July 2004 | - | -$32.80 K |
FAQ
- What is Summit Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Summit Therapeutics?
- What is Summit Therapeutics annual shareholders equity year-on-year change?
- What is Summit Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Summit Therapeutics?
- What is Summit Therapeutics quarterly shareholders equity year-on-year change?
What is Summit Therapeutics annual stockholders equity?
The current annual shareholders equity of SMMT is $77.69 M
What is the all time high annual shareholders equity for Summit Therapeutics?
Summit Therapeutics all-time high annual stockholders equity is $126.65 M
What is Summit Therapeutics annual shareholders equity year-on-year change?
Over the past year, SMMT annual stockholders equity has changed by -$48.96 M (-38.66%)
What is Summit Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SMMT is $437.92 M
What is the all time high quarterly shareholders equity for Summit Therapeutics?
Summit Therapeutics all-time high quarterly stockholders equity is $437.92 M
What is Summit Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SMMT quarterly stockholders equity has changed by +$338.54 M (+340.66%)